Cargando…
Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
Adoptive T cell therapy (ACT) holds great promise for cancer treatment. One approach, which has regained wide interest in recent years, employs antitumor T cells isolated from tumor lesions (“tumor-infiltrating lymphocytes” or TIL). It is now appreciated that a considerable proportion of anti-melano...
Autores principales: | Weinstein-Marom, Hadas, Gross, Gideon, Levi, Michal, Brayer, Hadar, Schachter, Jacob, Itzhaki, Orit, Besser, Michal J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817656/ https://www.ncbi.nlm.nih.gov/pubmed/33488585 http://dx.doi.org/10.3389/fimmu.2020.584148 |
Ejemplares similares
-
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017) -
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
por: Rozenbaum, Meir, et al.
Publicado: (2020) -
Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy
por: Blokon-Kogan, Dayana, et al.
Publicado: (2022) -
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
por: Yunger, Sharon, et al.
Publicado: (2019) -
Implementing Logic Gates for Safer Immunotherapy of Cancer
por: Savanur, Mohammed Azharuddin, et al.
Publicado: (2021)